Pages that link to "Q52148950"

The following pages link to Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in oligodendroglial tumours. (Q52148950):

Displaying 20 items.

• IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI (Q33733375) (← links)
• Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI. (Q48117662) (← links)
• Noninvasive Assessment of IDH Mutational Status in World Health Organization Grade II and III Astrocytomas Using DWI and DSC-PWI Combined with Conventional MR Imaging. (Q48222832) (← links)
• Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI. (Q48307043) (← links)
• Prediction of IDH1-Mutation and 1p/19q-Codeletion Status Using Preoperative MR Imaging Phenotypes in Lower Grade Gliomas. (Q48331864) (← links)
• Glioma imaging in Europe: A survey of 220 centres and recommendations for best clinical practice. (Q51416304) (← links)
• Texture analysis- and support vector machine-assisted diffusional kurtosis imaging may allow in vivo gliomas grading and IDH-mutation status prediction: a preliminary study. (Q52582028) (← links)
• Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation of IDH1-Mutation and 1p/19q-Codeletion Status in World Health Organization Grade II Gliomas. (Q53080016) (← links)
• Imaging scoring systems for preoperative molecular diagnoses of lower-grade gliomas. (Q55457239) (← links)
• Contrast enhancement predicting survival in integrated molecular subtypes of diffuse glioma: an observational cohort study. (Q55457283) (← links)
• Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis. (Q55457409) (← links)
• Predicting IDH mutation status of intrahepatic cholangiocarcinomas based on contrast-enhanced CT features (Q57123557) (← links)
• Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas (Q58135337) (← links)
• Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas (Q60636540) (← links)
• Noninvasively evaluating the grading and IDH1 mutation status of diffuse gliomas by three-dimensional pseudo-continuous arterial spin labeling and diffusion-weighted imaging (Q88733057) (← links)
• Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis (Q90019041) (← links)
• Increased intratumoral infiltration in IDH wild-type lower-grade gliomas observed with diffusion tensor imaging (Q90156126) (← links)
• 2-Hydroxyglutarate MR spectroscopy for prediction of isocitrate dehydrogenase mutant glioma: a systemic review and meta-analysis using individual patient data (Q90313239) (← links)
• Prediction of IDH Status Through MRI Features and Enlightened Reflection on the Delineation of Target Volume in Low-Grade Gliomas (Q90350274) (← links)
• Radiological differences between subtypes of WHO 2016 grade II-III gliomas: a systematic review and meta-analysis (Q97543205) (← links)